Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate

Bipolar Disorder

Predictive factors of functional outcome in patients with bipolar I disorder: a five-year follow-up

J Affect Disord.

López-Villarreal A, Sánchez-Morla EM, Jiménez-López E, Martínez-Vizcaíno V, Aparicio AI, Mateo-Sotos J, Rodriguez-Jimenez R, Vieta E, Santos JL

doi: 10.1016/j.jad.2020.03.140.

Bipolar Disorder

Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review

doi: 10.1016/j.euroneuro.2019.02.003.

Anxiety and DepressionBipolar DisorderPsychosis and Schizophrenia

Diagnostic conversion from unipolar depression tobipolar disorder, schizophrenia,or schizoaffective disorder:a nationwide prospective15-yearregister study on 43,495 inpatients

Bipolar Disord.

Baryshnikov I, Sund R, Marttunen M, Svirskis T, Partonen T, Pirkola S, Isometsä E

doi: 10.1111/bdi.12929.

Aging and Cognitive FunctionsBipolar DisorderPsychosis and Schizophrenia

Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis

Bipolar Disord.

Bowie CR, Best MW, Depp C, Mausbach BT, Patterson TL, Pulver AE, Harvey PD

doi: 10.1111/bdi.12654.

Psychosis and Schizophrenia

A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients

Prog Neuropsychopharmacol Biol Psychiatry.

Huang M, Yu L, Pan F, Lu S, Hu S, Hu J, Chen J, Jin P, Qi H, Xu Y

doi: 10.1016/

Psychosis and Schizophrenia

Demographic and clinical features as predictors of clozapine response in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis

Neurosci Biobehav Rev.

Okhuijsen-Pfeifer C, Sterk AY, Horn IM, Terstappen J, Kahn RS, Luykx JJ

doi: 10.1016/j.neubiorev.2020.01.017.

Aging and Cognitive Functions

A pilot randomized controlled trial of the Occupational Goal Intervention method for the improvement of executive functioning in patients with treatment-resistant schizophrenia

Psychiatry Res.

Vizzotto AD, Celestino DL, Buchain PC, Oliveira AM, Oliveira GM, Di Sarno ES, Napolitano IC, Elkis H

doi: 10.1016/

Bipolar Disorder

Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review

J Affect Disord.

Amerio A, Odone A, Ghaemi SN

doi: 10.1016/j.jad.2019.02.024.

Aging and Cognitive FunctionsPsychosis and Schizophrenia

Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries

Expert Opin Pharmacother.

Garay RP, Citrome L, Samalin L, Liu CC, Thomsen MS, Correll CU, Hameg A, Llorca PM

doi: 10.1517/

Related content

Predictive factors of functional outcome in patients with bipolar I disorder: a five-year follow-up

Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review

Diagnostic conversion from unipolar depression tobipolar disorder, schizophrenia,or schizoaffective disorder:a nationwide prospective15-yearregister study on 43,495 inpatients

Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis

A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients

Demographic and clinical features as predictors of clozapine response in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis

A pilot randomized controlled trial of the Occupational Goal Intervention method for the improvement of executive functioning in patients with treatment-resistant schizophrenia

Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review

Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries